Study of Teleo Virtual Therapy vs Standard Video for Children Ages 5 to 14 with Mood or Anxiety Disorders

What this Trial Is About

Researchers are evaluating how tailored telehealth psychotherapy environments affect clinical outcomes for children with mood and anxiety disorders. This Phase II randomized trial compares Teleo, a virtual therapy platform designed specifically for youth psychotherapy, to standard video conferencing platforms like Zoom. The study will assess patient engagement and various clinical metrics including treatment duration, medication needs, and symptoms of anxiety and depression. Participants will be randomly assigned to receive 12 sessions of therapist-led psychotherapy either through the Teleo platform or standard video conferencing methods. Sessions will be recorded, and clinical data along with questionnaires will be collected. The trial will monitor cancellation and no-show rates, clinician satisfaction, and treatment dropout over a 12-week period. Families involved in the study will complete assessments such as the Child Involvement Rating Scale during the first week and repeated measures of anxiety, depression, and therapy perceptions at multiple points. Researchers will also track long-term care costs one year after enrollment. Participation includes regular therapy sessions and questionnaire completion, with ongoing evaluation of both clinical and engagement outcomes until the study ends in 2027.

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings